NewsRoom Articles - Page 512 of 591

TuesdaySep 25, 2018 4:20 am

420 with CNW – Study Suggests CBD Could Treat Psychosis

Researchers from King’s College London have found that a cannabis extract, cannabidiol (CBD), can reset the brain so that the abnormal reactions characteristic of psychosis is reduced. Their findings were published in the JAMA Psychiatry journal. The researchers were led by Sagnik Bhattacharyya, PhD., who works at King’s College London at the Institute of Psychiatry, Psychology and Neuroscience. The team recruited 33 young people who hadn’t been diagnosed with psychosis but displayed the classic symptoms of that condition. Nineteen control subjects were also included in the study. These study subjects were divided into three groups. One group had the control…

MondaySep 24, 2018 4:20 pm

420 with CNW – Coca-Cola May Make Marijuana-Infused Drinks

News coming in about the carbonated beverages giant Coca-Cola (NYSE: KO) shows that the company is seriously thinking about a new product line of “wellness” drinks that are infused with cannabidiol (CBD), one of the non-psychoactive ingredients in cannabis. News of Coca-Cola’s interest emerged after it was revealed that the company was engaged in talks with Aurora Cannabis, Inc. about the possibility of partnering to make those wellness drinks. Coca-Cola was itself cagey about the possibility of making the drinks, only saying that it was watching with keen interest the development of CBD in the rapidly evolving cannabis industry. The…

MondaySep 24, 2018 2:06 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) “Gets It Right” in Cannabinoid Extraction

Sol-gel nose-to-brain system offers superior drug delivery New extraction protocol makes accurate and precise quantification of cannabinoids possible Establishment of cannabis division to commercialize research developments A recent release from PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) shows that, in cannabinoid extraction technology, the health sciences company is getting it right. The company announced that, during its soluble gel drug delivery research and development program – the Sol-gel Program – it had successfully optimized the conditions for extracting cannabinoids from one of its cannabis strains and developed a proprietary method – the Extraction Protocol – for the accurate…

MondaySep 24, 2018 12:57 pm

Inaugural Cannabis Strategic Ventures, Inc. (NUGS) and True Promise Beauty CBD-Based Product Line Set to Be Launched by Year-End 2018

The first products resulting from the joint venture between Cannabis Strategic Ventures and True Promise Beauty are scheduled to be launched by the end of 2018 The CBD-based luxury cosmetics line will feature face, skin and hair care products These products feature innovative formulations that aren’t currently available; the two companies hope to achieve strategic success in a constantly expanding luxury skin care market Cannabis Strategic Ventures, Inc. (OTC: NUGS) and True Promise Beauty have announced the development of LYXR – a new line of cannabidiol (CBD)-based luxury skin and hair care products. The entire LYXR line will be developed…

MondaySep 24, 2018 4:20 am

420 with CNW – Utah Set to Vote on Legalization of Medical Cannabis

Voters in Utah are set to vote on a bill (Proposition 2) that would legalize access to medical cannabis. The polls are slated for November 6, 2018. Prop 2 is unique from other mid-term issues to be voted upon because it originated from voters themselves rather than from their elected leaders. Over 113,000 voter signatures were collected in order to get this matter on the ballot. Under the proposed law, individuals with a health condition that meets the requirements stated in the Act can get a recommendation from a doctor. That recommendation can then be used to apply for a…

FridaySep 21, 2018 4:20 pm

420 with CNW – UC San Diego Researchers to Study Effect of Cannabis on Essential Tremors

Researchers at the University College San Diego have announced their intention to investigate the effect of using cannabis extracts to treat or manage essential tremor. The announcement came after the group of researchers (led by Dr. Fatta Nahab) got permission from the DEA (Drug Enforcement Administration) to import capsules of CBD and THC from Tilray, a Canadian-based cannabis company. Tilray conducted an initial public offering (IPO) in the U.S. The researchers opted to import the capsules since none are available from the sole source of cannabis for research purposes (University of Mississippi). Capsules were preferred for this study because of…

FridaySep 21, 2018 1:21 pm

Tilray, Inc.’s (NASDAQ: TLRY) Status as Global Pioneer in Cannabis Production, Distribution Reinforced by Earnings, Growth

First medical cannabis producer in North America to meet rigorous standards of GMP certification, supplying cannabis flower and extracts Canadian federally-licensed cannabis cultivator, processor and distributor Q2 2018 revenue increased to $9.7 million, up 95.2 percent over second quarter of 2017 Multinational distribution network makes Tilray medical cannabis available to patients in 11 countries on five continents Raised $163.6 million in a successful IPO in July 2018 and $55 million from leading institutional investors prior to IPO Agreements signed to supply medical cannabis via Canadian pharmacies and recreational cannabis to adult-use consumers in seven Canadian provinces and territories Received U.S.…

FridaySep 21, 2018 12:49 pm

ChineseInvestors.com, Inc. (CIIX) Expands North American Footprint for Chinese-Language News, CBD Product Market

ChineseInvestors.com sees astounding 28,859 percent revenue growth in CBD product brands Company tapping into economic potential of huge ethnic Chinese population in China and North America Company delivers education and analysis in Chinese on all aspects of cryptocurrency production and trade A financial information company dedicated to empowering Chinese-speaking investors and building on the market potential of cannabis-infused health and wellness products is announcing the expansion of its footprint in North America with the opening of offices in eastern Canada. ChineseInvestors.com, Inc. (OTCQB: CIIX) issued a news release on September 17 stating that it now has a sales and support…

FridaySep 21, 2018 11:26 am

Earth Science Tech, Inc. (ETST) Sees Uplisting to OTCQB Venture Market as Key to Goal of being Global Leader in Cannabinoid Market

Biotech company is focused on becoming a worldwide leader in R&D and sale of hemp-derived, CBD-based nutraceuticals, pharmaceuticals and dietary supplements ETST is developing three new CBD formulas in Canada under a provisory patent; it is also clinical testing its Hygee medical device for detecting sexually transmitted diseases in women With its Form 10 Registration Statement filing now effective, ETST will begin reporting annual, quarterly and periodic financial statements Earth Science Tech, Inc. (OTCQB: ETST) anticipates that its uplisting to the OTCQB Venture Market will enable it to reach global recognition and increase liquidity as a leader in the hemp-based…

FridaySep 21, 2018 11:23 am

Will Canopy Growth’s Spin-Off Canopy Rivers Be A Powerful Growth Engine?

Canopy Growth will reduce exposure to dilution and debt with the investment model of the new company. The business model of Canopy Rivers has one major flaw. The way Canopy Rivers must be analyzed in order to understand its growth potential. Canopy Growth (NYSE: CGC) is near to spinning off its new financial investment company called Canopy Rivers into a publicly traded firm, which will pursue investment opportunities in the growing cannabis sector. With a business model that has done extremely well for companies in other markets, if it is able to successfully leverage the model, Canopy Rivers has the…